GNBT - Generex Biotechnology Corporation Other OTC - Other OTC Delayed Price. Currency in USD 0.1780 -0.0220 (-11.00%) At close: 3:59PM EDT. 24 September 2020
Announcement Info Company Name BINTAI KINDEN CORPORATION BERHAD Stock Name BINTAI Date Announced 25 Sep 2020 Category Additional Listing Announcement /Subdivision of Shares Reference Number ALA-25092020-00004
1. Details of Corporate Proposal
Involve issuance of new type/class of securities ? No
Types of corporate proposal Private Placement
Details of corporate proposal Private placement of 28,700,000 new ordinary shares in Bintai Kinden Corporation Berhad representing approximately 10% of the total number of issued shares of the Company
No. of shares issued under this corporate proposal 28,700,000
Issue price per share ($$) Malaysian Ringgit (MYR) 0.5200
Latest issued share capital after the above corporate proposal in the following
Units 318,291,740
Issued Share Capital ($$) Malaysian Ringgit (MYR) 74,435,042.000
This 3 day old chart formation has just broken to the downside at 3 pm when it fell below 0.72. It is now on its way to 0.60 enroute to 0.36 again. Escape now n lick yr wound b4 the pain becomes unbearable.
paulthesotong Who the strategy partners that took 28.7 million at .52?
On behalf of the Board, KAF IB wishes to announce that the Board had on 17 September 2020 (“Price-Fixing Date”) fixed the issue price for the placement of 28,700,000 Placement Shares at RM0.52 each (“Issue Price”). The Issue Price represents a discount of RM0.057 or 9.88% to the 5-day VWAMP of the BKCB Shares up to and including 15 September 2020 of RM0.577, being the last market day immediately preceding the Price-Fixing Date.
The purpose of money raised through Private Placement is to pay BKCB debts of RM160 million.
Private placement investors are the winners most of the time.
Lack of disclosure requirements on who are those investors, relationship with bod, management etc. Already many private placement at low price, Lambo, Fintec, Binapuri, Bornoil, etc.
The Board of Directors of BKCBwishesto announce that Bintai Kinden Corporation Berhad(“BKCB”)[Registration No. 199401005191 (89776-P)],has on 28 September2020entered intoaMemorandum of Understanding (“MOU”) with Institut Jantung Negara Sdn Bhd(“IJNSB”) [Registration No. 199201014291 (245794-V)], a company incorporated under the laws of Malaysia and having its registered office at 145, Jalan Tun Razak, 50400 Kuala Lumpur for establishing a strategic partnership between the parties and explore possible collaboration in the area of commercial development of Covid-19 Vaccine in Malaysia (“Project”) subject to terms and conditions of the MOU.
Private placement is common when the coy has high gearing ratio, then this is the way to increase fund. Many companies do this, including tech and telco companies. So when this happened, the counter will be suspended to avoid panic selling
BINTAI, BINTAI KINDEN CORPORATION BHD - + BINTAI - Trading Halt and Resumption of Trading 28 Sep 2020, 15:04 BINTAI - Trading Halt and Resumption of Trading BINTAI - Trading Halt and Resumption of Trading ILC-28092020-00006 Kindly be advised that trading in the above Company's shares has been halted with effect from 2.50 p.m., Monday, 28 September 2020. Trading in the shares will resume with effect from 3.50 p.m., Monday, 28 September 2020. Your attention is drawn to the Company's announcement dated 28 September 2020. SVP, Issuers You are advised to read the entire contents of the announcement or attachment. To read the entire contents of the announcement or attachment, please access the Bursa website at http://www.bursamalaysia.com
i) BKCB is responsible to introduction of the Covid-19 Vaccine into Malaysia based on the 3 stages set out therein; (ii) All clinical test required by the MOH will be performed by and led by IJNSB (iii) IJNSB shall be the Clinical Research Organization (“CRO”) and one of the study sites for BKCB; and (iv) Other areas of mutual interest in which both parties have mutually agreed to from time to time; (hereinafter referred to as “the Cooperation”)
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
hahman
121 posts
Posted by hahman > 2020-09-25 09:18 | Report Abuse
Bintai can’t compare with solutn. Because China vaccine advance than US